Furthermore, Patients previously diagnosed with CACT deficiency was reviewed systematically by describing the clinical, biochemical, and genetic characteristics and treatment to improve our understanding of this rare disorder. This evidence concerns the gene SLC25A20 and hyperinsulinemic hypoglycemia, familial, 4.